Exenatide Clinical Trial

TITLE:
A Randomized Trial Comparing Exenatide With Placebo in Subjects With Type 2 Diabetes on Insulin Glargine With or Without Oral Antihyperglycemic Medications

PURPOSE:
The study is designed to compare the efficacy and safety of exenatide plus titration of basal insulin to placebo plus titration of basal insulin, with or without oral antihyperglycemic medications, in adult subjects with type 2 diabetes mellitus who are suboptimally controlled

PHASE:
3b

INSTITUTIONAL REVIEW BOARD:
Western Institutional Review Board

STATUS:
Closed

ELIGIBILITY:
Adults aged 18 years and over with type 2 diabetes mellitus who have been taking basal insulin glargine at >20 units per day for 3 months with a an HbA1c >7.1% and <10%

DURATION:
14 visits over 30 weeks

Prinicpal Investigator:
Jeffrey Bauman, MD

CONTACT:
Kelly Ritter, CCRC
908-277-8747